Genome-Based Therapeutics: Targeted Drug Discovery and Development
Publisher: National Academies Press 2012
Number of pages: 89
Objectives: To examine the impact of and investment in genetic and genomic technologies and data in drug discovery and development; To examine and discuss the challenges for incorporating genomic technologies into drug development and to explore solutions to remedy those challenges; To discuss and explore how innovative, novel, and global partnerships between academia, industry, foundations, and government can enable the use of genomic information for more efficient and effective drug discovery and development programs.
Home page url
Download or read it online for free here:
by Niels Bindslev - Co-Action Publishing
This book is a survey of, and evaluates, analytical tools used to determine equilibrium effects of the interactions between ligands and receptive units as obtained from dose-response experimentation and from combinatorial drug therapy.
by Cecilia Maldonado - InTech
This book comprises many aspects of pain treatment and the drugs involved in it. From old analgesics for pain alleviation to analgesics potential for diminishing oxidative stress; from pharmacological therapies to electrical ones ...
by Tarek A Leil, Sergey Ermakov (eds) - Frontiers Media S.A.
Quantitative Systems Pharmacology is still in its infancy, but has tremendous potential to change the way we approach biomedical research. QSP is really the integration of two disciplines: 'Systems Biology' and 'Quantitative Pharmacology'.
by J. Eric McDuffie (ed.) - InTech
Because the incidence of neurobehavioral hazards and risks of exogenous compounds remain subject matter of interest, predictive tools have evolved, including novel translational in vitro models, biomarkers, newer epidemiological research tools, etc.